NRX Pharmaceuticals, Inc. Share Price
NRXPNRX Pharmaceuticals, Inc. Stock Performance
Open $4.08 | Prev. Close $4.04 | Circuit Range N/A |
Day Range $3.94 - $4.26 | Year Range $1.64 - $5.05 | Volume 1,52,953 |
Average Traded $4.07 |
NRX Pharmaceuticals, Inc. Share Price Chart
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
05-Jun-26 | $4.08 | $4.15 | +0.00% |
05-Jun-26 | $4.08 | $4.15 | +2.47% |
04-Jun-26 | $3.97 | $4.05 | +0.50% |
03-Jun-26 | $3.61 | $4.03 | -12.58% |
02-Jun-26 | $4.64 | $4.61 | -0.32% |
01-Jun-26 | $4.57 | $4.63 | +4.40% |
29-May-26 | $4.46 | $4.43 | -0.34% |